THE WIRE
What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Key
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.
- CRHCRH Public LTD CoOther events.−5.5%8-K 8.01 ↗
- HAVAHarvard Ave Acquisition CorpPassive stake of 5% or more (13G), filed by Highbridge Capital Management.+0.1%13G ↗
- SLDBSolid Biosciences IncPassive stake of 5% or more (13G), filed by RTW Investments.−8.6%13G ↗
- CNTNCanton Strategic Holdings, IncResults of operations.
Canton Strategic Holdings, Inc. Releases Third Quarter 2026 Financial and Operational Results Total revenue of $3 million, an increase of 104% since Q2, in the Company’s first full quarter of Super…
−29.2%8-K 2.02 ↗ - THEOBOA Acquisition Corp. IIPassive stake of 5% or more (13G), filed by Highbridge Capital Management.+0.1%13G ↗
- CYCUCycurion, IncOther events.
Cycurion Reports Record Quarterly Revenue and Gross Profit as Revenue Grows 40% and Gross Margin Reaches 36% Revenue exceeds Wall Street consensus estimate of $4.37 million Gross Profit More Than…
−31.4%8-K 8.01 ↗ - USDEStableCoinX IncResults of operations.−33.8%8-K 2.02 ↗
- SLESuper League Enterprise, IncMaterial agreement and other events.−20.0%8-K 1.01 ↗
- APVOAptevo Therapeutics IncResults of operations.−32.0%8-K 2.02 ↗
- CRDFCardiff Oncology, IncPassive stake of 5% or more (13G), filed by Highbridge Capital Management.+17.4%13G ↗
- NMPNMP Acquisition CorpPassive stake of 5% or more (13G), filed by Highbridge Capital Management.0.0%13G ↗
- CEPOCantor Equity Partners I, IncPassive stake of 5% or more (13G), filed by Highbridge Capital Management.+0.1%13G ↗
- FCXFreeport-McMoran IncOther events.−22.4%8-K 8.01 ↗
- WENNWEN Acquisition CorpPassive stake of 5% or more (13G), filed by Highbridge Capital Management.0.0%13G ↗
- FJDIARC Group Securities Acquisition IPassive stake of 5% or more (13G), filed by Highbridge Capital Management.13G ↗
- OTAIStarlink AI Acquisition CorpPassive stake of 5% or more (13G), filed by Highbridge Capital Management.−0.1%13G ↗
- IPDNProfessional Diversity Network, IncResults of operations and Regulation FD disclosure.−18.2%8-K 2.02 ↗
- HSDTSolana CoPassive stake of 5% or more (13G), filed by Highbridge Capital Management.−13.9%13G ↗
- PYXSPyxis Oncology, IncPassive stake of 5% or more (13G), filed by RTW Investments.+14.6%13G ↗
- YCYAA Mission Acquisition Corp. IIPassive stake of 5% or more (13G), filed by Highbridge Capital Management.−0.2%13G ↗
- NCOSouthern Cross Acquisition I CorpPassive stake of 5% or more (13G).+0.3%13G ↗
- SCIISC II Acquisition CorpPassive stake of 5% or more (13G), filed by Highbridge Capital Management.+0.2%13G ↗
- ARCTArcturus Therapeutics Holdings IncMaterial agreement and unregistered sale of shares.−10.9%8-K 1.01 ↗
- QLEPQuantum Leap Acquisition CorpPassive stake of 5% or more (13G), filed by Highbridge Capital Management.+0.2%13G ↗
- EMPDEmpery Digital IncRegulation FD disclosure and other events.−9.1%8-K 7.01 ↗
- MBOTMicrobot Medical IncRegulation FD disclosure.
Microbot Medical® Files 10-Q and Highlights Key Third Quarter Operating Achievements Company continues to expand commercial presence in the U.S. while it progresses international market entry and…
−30.5%8-K 7.01 ↗ - HCWBHCW Biologics IncResults of operations.
HCW Biologics Reports Third Quarter 2026 Business and Clinical Development Highlights and Financial Results
−3.1%8-K 2.02 ↗ - RENXRenX Enterprises CorpResults of operations.−42.5%8-K 2.02 ↗
- CATXPerspective Therapeutics, IncA director bought $15K of stock.$15K−20.1%Form 4 ↗
- CATXPerspective Therapeutics, IncA director bought $21K of stock.$21K−20.1%Form 4 ↗
- CATXPerspective Therapeutics, IncA director bought $20K of stock.$20K−20.1%Form 4 ↗
- HTCRHeartCore Enterprises, IncResults of operations.
HeartCore Reports Third Quarter 2026 Financial Results
−7.2%8-K 2.02 ↗ - PCTPureCycle Technologies, IncThe Executive Chairman bought $98K of stock.$98K−7.6%Form 4 ↗
- AIOTPowerfleet, IncOfficer or director change and other events.
Manhattan Associates Chairman and former CEO and former Jamf CEO bring extensive enterprise software, supply chain and SaaS leadership experience
−22.6%8-K 5.02 ↗ - CDRECadre Holdings, IncOfficer or director change.−11.9%8-K 5.02 ↗
- LRMRLarimar Therapeutics, IncPassive stake of 5% or more (13G), filed by RTW Investments.+4.0%13G ↗
- FLSFlowserve CorpPassive stake of 5% or more (13G), filed by D1 Capital Partners.−7.7%13G ↗
- WYYWidepoint CorpResults of operations.
TRANSCRIPT OF EARNINGS CALL
+8.3%8-K 2.02 ↗ - DXDynex Capital IncThe Co-CEO & Chairman of the Board bought $50K of stock.$50K−2.3%Form 4 ↗
- DXDynex Capital IncThe Co-CEO and President bought $26K of stock.$26K−2.3%Form 4 ↗
- COMPCompass, IncPassive stake of 5% or more (13G), filed by D1 Capital Partners.−5.6%13G ↗
- EFOREverforth IncOther events.
Everforth, Inc. to Offer $500 Million Senior Notes
−11.9%8-K 8.01 ↗ - TLSITriSalus Life Sciences, IncA director bought $112K of stock.$112K−4.5%Form 4 ↗
- MAIRMadison Air Solutions CorpPassive stake of 5% or more (13G), filed by D1 Capital Partners.−7.5%13G ↗
- ACNBAcnb CorpRegulation FD disclosure.−3.3%8-K 7.01 ↗
- VTIXVirtuix Holdings IncResults of operations and Regulation FD disclosure.
Total Quarterly Revenue Rises 55% Sequentially to $1.2 Million Following Meta Quest Launch Enterprise Orders Increase 45% as Virtuix Expands Robotics, Defense, and Healthcare Applications Company…
−37.3%8-K 2.02 ↗ - CGONCG Oncology, IncRegulation FD disclosure and other events.+6.8%8-K 7.01 ↗
- CCCTColumbus Circle Capital Corp IIIPassive stake of 5% or more (13G), filed by Verition Fund Management.0.0%13G ↗
- DWSNDawson Geophysical CoResults of operations.−8.3%8-K 2.02 ↗
- AKBAAkebia Therapeutics, IncMaterial agreement and unregistered sale of shares.
Akebia Enters into Term Loan Facility with Symbiotic Capital Worth Up to $140 Million Initial $60 million tranche fully funded, proceeds of which were used to fully repay $55 million BlackRock loan…
−18.7%8-K 1.01 ↗